The Drugs That Could Face US Generic/Biosimilar Competition In 2021

Lucentis Tops The List

 
• By Jessica Merrill

Other expected generics include Viatris' Perforomist (formoterol fumarate), Pfizer's Sutent (sunitinib), Sanofi's Jevtana (cabazitaxel) and possibly Boehringer Ingelheim's Pradaxa.

Waving Goodbye
Say goodbye to the drugs that will go generic in 2021 • Source: Alamy

More from New Products

More from Scrip